New treatment to slow vision loss from macular degeneration

There's a condition around age 50 or later where you can get a spot in your field of vision. It can possibly grow to lead to total loss of vision. About a million Americans have this form of macular degeneration, and now they have a new hope. The FDA just approved an injectable medicine called Syfovre.

The drug will come out on the market sometime in early March. It does not reverse macular degeneration. It slows down the progression of sight loss.

You'll need an injection every one to two months. And the medicine cost $2,190 a vial. One professor from Duke University helped oversee a clinical study of Syfovre. Dr. Elenora Lad says it's "a game changer" and the "beginning of a new treatment era for patients."



Follow us:

Download the WFMY News 2 app:
►Text the word APP to 336-379-5775

[PARROTBAYJP]

I agree, fix the price, is it 21190 or 2, 190, per vial, still expensive though?

[margaretputnam]

You need to fix that price. ON the video it says $21190 not $2190.